NCT01703754 2025-08-28
Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.
Alaunos Therapeutics
Phase 2 Terminated
Clinical Trials
3 trialsNCT02423902 2025-08-28
A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Breast Cancer
Alaunos Therapeutics
Phase 1/2 Terminated
NCT04006119 2025-04-18
Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma
Alaunos Therapeutics
Phase 2 Terminated